Drug manufacturers have agreed to increase their production of stimulant medications like Adderall to help address the ongoing shortage in the U.S., with the Drug Enforcement Administration (DEA) making changes to its quota process. The U.S. is experiencing a shortage of several stimulant drugs, including Adderall, Ritalin and Vyvanse. The Adderall shortage has gone on…
Anshul Mangal, biotech entrepreneur, attorney, CEO, and founder of Project Farma, discusses how supply chain disruptions and the current cancer drug shortage are affecting patients.